Novartis to Acquire UK-Based Myricx Bio in Deal Worth Up to $1.5 Billion
Swiss Drugmaker Expands Cancer Portfolio With Next-Generation Antibody-Drug Conjugate Technology Swiss pharmaceutical giant Novartis has agreed to acquire UK biotechnology ...
Swiss Drugmaker Expands Cancer Portfolio With Next-Generation Antibody-Drug Conjugate Technology Swiss pharmaceutical giant Novartis has agreed to acquire UK biotechnology ...
The agreement gives Innovent Biologics exclusive commercialization rights for Eli Lilly's breast cancer drug Verzenios in mainland China, as the ...
I don’t want startup news.
I don’t want startup news.